Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case

Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case

Hypertrophic cardiomyopathy (HCM) is a disease that is usually unresponsive to conservative pathogenetic therapy. It does not have clearly developed surgical correction algorithms. Heart transplantation (HTx) is the sole therapeutic option when drug therapy is ineffective and surgical reduction of h...

Full description

Bibliographic Details
Main Authors: M. R. Zaynetdinov, M. N. Mukharyamov, R. K. Dzhordzhikiya, I. I. Vagizov, M. A. Miroshnichenko, I. V. Abdulyanov, R. R. Khamzin, D. I. Abdulganieva, E. V. Dyakova, A. Zh. Bayalieva, N. F. Gizatullina, N. Yu. Stekolshchikova, M. M. Minnullin, R. N. Khairullin
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2022-07-01
Series:Вестник трансплантологии и искусственных органов
Subjects:
hypertrophic cardiomyopathy
heart transplantation
covid­19
Online Access:https://journal.transpl.ru/vtio/article/view/1483

Internet

https://journal.transpl.ru/vtio/article/view/1483

Similar Items